Maureen Bernadach

Combination of monalizumab and cetuximab in recurrent or metastatic head and neck cancer patients previously treated with platinum-based chemotherapy and PD-(L)1 inhibitors.

Roger B. Cohen, Jessica R. Bauman, Sébastien Salas et al. · Journal of Clinical Oncology · 2020 · 40 citations

Immunology, Immunoediting, Pathology +23

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers

Maureen Bernadach, M. Lapeyre, Anne-Françoise Dillies et al. · BMC Cancer · 2021 · 28 citations · Full text

Prognosis in Head and Neck Cancer: Importance of Nutritional and Biological Inflammatory Status

N. Saroul, M. Puechmaille, Céline Lambert et al. · Otolaryngology · 2021 · 23 citations

Sister Mary Joseph Nodules: A Case Report about a Rare Location of Skin Metastasis

Brice Leyrat, Maureen Bernadach, Angeline Ginzac et al. · Case Reports in Oncology · 2021 · 16 citations · Full text

Skin Infiltration, Surgical Oncology, Pathology +20